Joseph Tung - 28 Feb 2025 Form 3 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Reporting relationship: Director
Issuer ticker: SHPH
Reported as of: 28 Feb 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 21 Mar 2025, 20:00:06 UTC
Next SEC filing: 09 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Joseph Tung

Key filing fact

Joseph Tung filed Form 3 for Shuttle Pharmaceuticals Holdings, Inc. (SHPH) on 21 Mar 2025.

Key facts

This page summarizes Joseph Tung's Form 3 filing for Shuttle Pharmaceuticals Holdings, Inc. (SHPH).
0 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 21 Mar 2025, 20:00.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SHPH holding

COMMON STOCK

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 184,162
Date: 28 Feb 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The undersigned became a Reporting Person subject to Section 16 reporting on February 28, 2025. The Reporting Person received a grant of 184,162 restricted stock units ("RSUs") on March 5, 2025, which RSUs are subject to vesting over a period of three years, on February 28, 2026, February 28, 2027, and February 28, 2028.

Footnote F2

Consists of 184,162 RSUs, which remain subject to vesting.